Biotech for Obama Presidency

Description:

One of the biggest impacts of the new administration could be in stem cell research, according to Laura Cadden. Support for the use of embryonic stem cells would open a whole world of opportunity for specialist biotech firms. Laura picks 5 small-cap biotech stocks that would make huge gains on new stem cell legislation.

Most Viewed Portfolios

View All

Articles

5 Toxic Stocks You Need to Sell Now

08.29.14 | 12:32 PM

BALTIMORE (Stockpickr) -- The S&P 500 is quickly closing in on the double-digit gains mark this summer, up more that 8% year-to-date as I write. At...

5 Breakout Stocks Under $10 Set to Soar

08.28.14 | 02:41 PM

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience m...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter